Filing Details
- Accession Number:
- 0001127602-17-015421
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2017-04-25 14:06:12
- Reporting Period:
- 2017-04-24
- Filing Date:
- 2017-04-25
- Accepted Time:
- 2017-04-25 14:06:12
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1090872 | Agilent Technologies Inc | A | Laboratory Analytical Instruments (3826) | 770518772 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1625775 | Patrick Kaltenbach | 5301 Stevens Creek Blvd Santa Clara CA 95051 | Sr Vice President | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2017-04-24 | 2,000 | $26.19 | 42,132 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2017-04-24 | 2,000 | $54.50 | 40,132 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (Right to Buy) | Disposition | 2017-04-24 | 2,000 | $0.00 | 2,000 | $26.19 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2013-11-21 | 2022-11-20 | No | 4 | M | Direct |
Footnotes
- This transaction was effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on March 6, 2017.
- Right to buy Agilent Technologies, Inc. common stock granted under the Agilent Technologies, Inc. Stock Plan, in compliance with Rule 16b-3.
- The option is fully vested and exercisable.
Billionaire Hedge Funds
